KA/EN
Register
Medicines reference
Search
Search
Product

Hipradog DHLP

Favourites

Canine parvovirus + Canine distemper virus + Canine adenovirus + Leptospira icterohaemorrhagiae + Leptospira canicola · Laboratorios HIPRA, S.A.

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Dog Dog 1 ml
Reconstitute fully with the liquid component and inject one 1 ml dose subcutaneously at 8 weeks, again at 12 weeks, then annually. Use within one hour. Vaccinate healthy, unstressed dogs without suspected intestinal parasites. Do not use during pregnancy. Hypersensitivity is very rare and requires immediate symptomatic treatment. Do not mix or co-administer another vaccine or medicine without a case-specific veterinary decision.
 · at 8 and 12 weeks, then annually		 at 8 and 12 weeks, then annually Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ჰიპრადოგი DHLP
№ 247-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Hipradog DHLP, Suspension

lyophilisate and suspension for injection, 1 ml dose for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.7/10
Good
vetman assessment

Hipradog DHLP

lyophilisate and suspension for injection, 1 ml dose for dogs
Assessed clinical scopeDog · Full dog label: active immunisation against CDV, CAV-1/2, CPV and leptospirosis caused by the labelled Canicola and Icterohaemorrhagiae serogroups · Subcutaneous
Care settingPreventive canine vaccination with examination, exposure-risk assessment, cold-chain control and emergency treatment available
vetman score 7.7/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 247-11 · Verified on 21 Oct 2026

A clinically useful DHP-plus-bivalent-leptospirosis vaccine with solid core-antigen rationale. Its narrow leptospiral breadth and legacy 8/12-week annual programme need deliberate adjustment to current protocols.

Regulatory and scientific credibility8.7/10

The exact combination and presentation are registered in Georgia and have a current regulator SPC with explicit antigen potency, schedule and safety information; duration support is mainly label and serology based.

Clinical efficacy7.0/10

The DHP viral antigens are strongly supported core targets, but the labelled puppy series ends at 12 weeks unless supplemented, annual repetition is assigned to all components, and bivalent leptospiral coverage is narrower than current four-component options.

Safety and tolerability7.8/10

The benefit-risk is generally favourable in healthy dogs and hypersensitivity is very rare; live viral components, pregnancy restriction and lack of established compatibility with other products require standard precautions.

Clinical practicality7.1/10

The fixed 1 ml combined SC dose is simple, but reconstitution, one-hour use, cold chain, two initial visits, annual repetition and a later guideline-concordant puppy dose add operational burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Vaccinate only healthy, unstressed dogs without suspected intestinal parasites.
  • Do not use during pregnancy.
  • The labelled 8- and 12-week course should be extended with a core dose at 16 weeks or later when maternal antibody is relevant.
  • Leptospiral coverage is limited to the Canicola and Icterohaemorrhagiae serogroups; assess whether broader local coverage is preferable.
  • Very rare hypersensitivity requires immediate symptomatic treatment and post-vaccination observation.
  • Do not mix or co-administer another vaccine or medicine without a case-specific veterinary decision.
  • Maintain the cold chain, reconstitute fully, use within one hour and do not let annual combination use replace component-specific planning.
Assessment sources
  1. EU UPD SPC 20262026
  2. WSAVA vaccination 20242024
  3. AAHA canine vaccination 20222022
  4. ACVIM leptospirosis consensus 20232023
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine parvovirus6 log10 TCID50/dose Canine distemper virus4 log10 TCID50/dose Canine adenovirus4 log10 TCID50/dose Leptospira icterohaemorrhagiae9 log10 org/dose Leptospira canicola9 log10 org/dose
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer
Laboratorios HIPRA, S.A. · Spain
Manufacturer (register)
Laboratorios HIPRA, S.A., Spain
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 294, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ჰიპრადოგი DHLP
№ 247-11
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml
Reconstitute fully with the liquid component and inject one 1 ml dose subcutaneously at 8 weeks, again at 12 weeks, then annually. Use within one hour. Vaccinate healthy, unstressed dogs without suspected intestinal parasites. Do not use during pregnancy. Hypersensitivity is very rare and requires immediate symptomatic treatment. Do not mix or co-administer another vaccine or medicine without a case-specific veterinary decision.
 Dog Any weight Subcutaneous at 8 and 12 weeks, then annually
EU UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Hipradog DHLP - official product information
EU Union Product Database, 2026

Canine parvovirus: No dose supported by a publicly verifiable source yet

Canine distemper virus: No dose supported by a publicly verifiable source yet

Canine adenovirus: No dose supported by a publicly verifiable source yet

Leptospira icterohaemorrhagiae: No dose supported by a publicly verifiable source yet

Leptospira canicola: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗